Contactin-1 autoimmunity
Open Access
- 1 July 2020
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology Neuroimmunology & Neuroinflammation
Abstract
Objective To determine serologic characteristics, frequency, phenotype, paraneoplastic associations, and electrodiagnostic and histopathologic features accompanying contactin-1 autoimmunity. Methods Archived sera known to produce synaptic tissue-based immunofluorescence patterns were reevaluated, and contactin-1 specificity was confirmed by recombinant protein assays. Screening of 233 chronic/relapsing demyelinating neuropathies for additional cases was performed. Results We identified 10 contactin-1 IgG seropositive cases. Frequency of contactin-1 immunoglobulin (Ig) G among tested Mayo Clinic chronic/relapsing demyelinating neuropathies was 2%. Sensory predominant presentations (n = 9, 90%), neuropathic pain (n = 6, 60%), and subacute progression (n = 5, 50%) were commonly encountered among contactin-1 neuropathies. Two patients had chronic immune sensory polyradiculopathy-like phenotype at presentation. Electrodiagnostic studies were consistent with demyelination (slowed conduction velocities and/or prolonged distal latencies) without conduction block. Markedly elevated CSF protein (median 222 mg/dL, range 69–960 mg/dL), thickening/gadolinium enhancement of nerve roots (4/5), and subperineural edema on nerve biopsy (4/4) were other characteristic features. Three cases were diagnosed with paraneoplastic demyelinating neuropathies (thymoma, n = 1; breast cancer, n = 1; plasmacytoma, n = 1). Four of the 9 patients treated with IV immunoglobulin demonstrated initial clinical improvement, but the favorable response was sustained in only 1 case (median follow-up, 60 months). Sustained clinical stabilization or improvement was observed among 3 of the 6 cases in whom second-line therapies (rituximab, cyclophosphamide, and azathioprine) were used. Conclusion Contactin-1 IgG has a distinct sensory predominant presentation commonly associated with neuropathic pain, with demyelinating changes on electrophysiologic studies. A paraneoplastic cause should be considered. Testing of contactin-1 IgG among cases with similar presentations may guide immunotherapy selection, especially second-line immunotherapy consideration.Keywords
This publication has 16 references indexed in Scilit:
- Endoneurial edema in sural nerve may indicate recent onset inflammatory neuropathyMuscle & Nerve, 2015
- Contactin 1 IgG4 associates to chronic inflammatory demyelinating polyneuropathy with sensory ataxiaBrain, 2015
- Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodiesJournal of Neurology, Neurosurgery & Psychiatry, 2015
- Incat disability score: A critical analysis of its measurement propertiesMuscle & Nerve, 2014
- Antibodies to contactin‐1 in chronic inflammatory demyelinating polyneuropathyAnnals of Neurology, 2012
- European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society – First RevisionJournal of the Peripheral Nervous System, 2010
- Long term prognosis of chronic inflammatory demyelinating polyneuropathy: a five year follow up of 38 casesJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Chronic immune sensory polyradiculopathyNeurology, 2004
- Patterns of nerve conduction abnormalities in POEMS syndromeMuscle & Nerve, 2002
- Focal lesions area feature of chronic inflammatory demyelinating polyneuropathy (CIDP).Acta Neuropathologica, 1998